| 摘要 |
<p>The present invention is concerned with compounds inhibiting CD95 signaling in pancreatic cancer cells. Furthermore, contemplated by the current invention are medicaments comprising such a compound for the prevention and / or treatment of pancreatic cancer as well as the use of such a compound for the manufacture of a medicament for the prevention and / or treatment of pancreatic cancer, the prevention of migration of cancer cells, and / or the prevention and / or treatment of an inflammatory reaction. The present invention also refers to a method for the identification of a compound inhibiting CD95 signaling, as well as to a method for the manufacture of a medicament comprising the steps of the method for the identification of a compound inhibiting CD95 signaling and the further step of formulating the inhibiting compound as a medicament.</p> |
